Loading clinical trials...
Loading clinical trials...
A Feasibility Study of Pre-Operative Sunitinib (SU11248) With Multiple Pharmacodynamic Endpoints in Patients With T1c-T3 Operable Carcinoma of the Breast
Conditions
Interventions
sunitinib malate
immunohistochemistry staining method
+4 more
Locations
2
Canada
British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
Edmond Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
Start Date
April 8, 2009
Primary Completion Date
March 15, 2010
Completion Date
January 18, 2011
Last Updated
February 12, 2024
NCT05468034
NCT04541381
NCT03137095
NCT07547774
NCT04852887
NCT06393374
Lead Sponsor
NCIC Clinical Trials Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions